Keywords: |
clinical article; controlled study; protein expression; protein phosphorylation; acute granulocytic leukemia; human cell; clinical trial; drug activity; doxorubicin; nonhuman; pathophysiology; drug megadose; animal cell; mouse; phenotype; animals; mice; cell cycle; protein bcl 2; apoptosis; controlled clinical trial; phase 2 clinical trial; gene expression; thrombocytopenia; cell line; cell differentiation; myelodysplastic syndrome; genetic transfection; cell culture; transcription factor e2f; cell line, transformed; cell polarity; cycline; protein p130; histone deacetylase; trichostatin a; wart virus; cinnamic acid derivative; solubility; histone h4; chemoprevention; methylnitrosourea; hydroxamic acid derivative; leukemia, erythroblastic, acute; myeloma cell; hybrid cell; hexamethylenebisacetamide; acetamides; human; article; virus cell transformation; apolipoprotein e7
|